Silver Book Fact

Goel S, Bajaj N, Agaarwall B, Gupta S, et al. Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure. J Am Coll Cardiol. 2014; 63(2). http://www.onlinejacc.org/content/63/2/185

Reference

Title
Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure
Publication
J Am Coll Cardiol
Publication Date
2014
Authors
Goel S, Bajaj N, Agaarwall B, Gupta S, et al.
Volume & Issue
Volume 63, Issue 2
URL
Read Full Resource

Categories

  • Cost of Disease

Related Facts

  • Medicare patients with sSAS have an average lifespan of 1.8 years without repair or replacement
     
  • Undertreatment of patients with sSAS
    AS is often undertreated — one study found that 56% of severe symptomatic aortic stenosis (sSAS) patients referred to a cardiothoracic surgeon were not operated on.  
  • Increased hospital admissions and prolonged length of stay for patients who do not undergo treatment
    Medicare severe symptomatic aortic stenosis (sSAS) patients who do not undergo treatment have an average of 1.9 hospital admissions per year and prolonged lengths of stay — 11.5 hospital days…  
  • 1 and 6-month mortality rates without treatment for sSAS
    Waiting for treatment for severe symptomatic aortic stenosis (sSAS) can be deadly, with 1-month mortality at 3.7% and 6-month mortality at 11.6% (measured from the time intervention was recommended).  
  • Survival Rates Over 5 Years for Patients with Medically Managed Severe Aortic Stenosis